67W-86190-10749 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-08
Dose 1 — Pfizer-BioNTech
2021-01-29
Dose 2 — Pfizer-BioNTech
2021-10-22
Registered in v-safe
2021-10-22
Dose 3 — Pfizer-BioNTech
2021-10-22
Health check-in — day 0, dose 3
Feeling: Fair · Site: Pain · None

Adult check-in
2021-10-23
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-11-14
Health check-in — day 21, dose 3
Feeling: Fair

Adult check-in
2022-01-21
Survey response — 3 months, dose 3
MedDRA: COVID-19, Decreased appetite, Fatigue, Headache, Malaise, Nausea, Respiratory tract congestion — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Have had Covid and was sick for a week with congestion, headache, fatigue, loss of appetite, nausea

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-08	Pfizer-BioNTech	No
2	2021-01-29	Pfizer-BioNTech	No
3	2021-10-22	Pfizer-BioNTech	No

Free text

Release 11 — 3 months, dose 3

2022-01-21

Symptoms: Have had Covid and was sick for a week with congestion, headache, fatigue, loss of appetite, nausea

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Decreased appetite	·	·	✓
SD	Fatigue	·	·	✓
SD	Headache	·	·	✓
SD	Malaise	·	·	✓
SD	Nausea	·	·	✓
SD	Respiratory tract congestion	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release